무제 문서
Userful Information
Items 1 ~ 10 of 20, Page 1 of 2
Guidance for Industry: Pharmaceutical Components at Risk for Melamine Contamination
08/06/2009 U. S. Food and Drug Administration (FDA)
Botulinum neurotoxin in the treatment of autonomic disorders and pain: an evidence-based review
05/31/2008 American Academy of Neurology (AAN)
Botulinum neurotoxin for the treatment of movement disorders: an evidence-based review
05/15/2008 American Academy of Neurology (AAN)
Botulinum neurotoxin for the treatment of spasticity: An evidence-based review
03/14/2008 American Academy of Neurology (AAN)
   
1 2 3 4 5